Pre-formulation research has gradually become a routine research project in the design and improvement of dosage forms and preparations, providing a basis for further designing dosage forms and optimizing the formulation process.
Medicilon has been offering high quality analytical testing services to the pharmaceutical industry for decades. We offer a wide range of quality control testing services to support drug research, registration and production. Biopharmaceutical companies also use many of the same services and Medicilon has also added new services to accommodate their unique needs (detailed in the following section).
Medicilon's preparation laboratory and workshop area is about 4,000 square meters, with 100 professional R&D teams, of which more than 40% are masters/doctors, and more than 95% are undergraduates. The team has rich experience in successful research and development of innovative drugs, consistency evaluation, and improved new drugs, and experience in China-US dual filing and project management. The Medicilon pharmaceutical preparation R&D team has successfully cooperated with well-known large and medium-sized pharmaceutical companies worldwide, and has accumulated 18 years of experience in the research and application of innovative drugs and generic drugs. We provide one-stop and systematic preparation R&D services covering innovative drugs and generic drugs to meet the needs of customers at different stages of R&D.
To assist preclinical research of RNA drugs, Medicilon and Acon Pharmaceuticals reached a strategic collaboration
World's First Inhaled Nanobody Drug LQ036
Medicilon assists Palaatu to obtain clinical approval for Class 1 new drug PA9159 for rhinitis
The main content of pre-prescription research work is to obtain various information required for dosage form and preparation design by consulting domestic and foreign documents or conducting experimental research, including physical properties, melting point, particle size, solubility, dissolution rate, crystal form, and pKa, partition coefficient, surface characteristics and other inherent physical and chemical properties of the drug, the stability of the drug, the compatibility of the drug and excipients, the pharmacology, side effects and irritation of the drug, and the absorption, distribution, metabolism and excretion of the drug in the body Wait.
Certain physical and chemical properties of drugs (such as drug solubility, dissolution rate, stability, etc.) and preparation operations and quality (such as powder fluidity, content uniformity, bioavailability, etc.) are often affected by particle size and particle size distribution .
Most solid dosage forms (such as powders, granules, tablets, capsules, etc.) require particle processing to improve powder properties to meet product quality and powder handling requirements. The particle size significantly affects the oral absorption of certain drugs, such as griseofulvin and spironolactone. Therefore, it is very important to understand the impact of drug particle size on formulation prescription and product effectiveness as early as possible.
According to different particle sizes, the sieving method (pharmacopoeia sieve), sedimentation method (Coulter counter) microscopy (optical microscope, scanning electron microscope, transmission electron microscope) can be used to determine the particle size and particle size distribution of the drug.
The solubility of a drug is one of the primary factors that need to be considered in the design of drug formulations and preparations. No matter how the drug is administered, it must have a certain degree of water solubility in order to be absorbed by the body and have a therapeutic effect. Drugs with poor solubility (solubility in water<10mg/ml) often show incomplete or unstable absorption. If the solubility of the drug is lower than the expected value, it is necessary to consider adopting appropriate methods to increase its solubility.
The determination of drug solubility often uses the shake flask method. Generally, the excess drug is placed in the solvent to be measured, shaken at a certain temperature, and the drug concentration after the equilibrium is measured is its solubility. It usually takes 60 to 72 hours of shaking to reach equilibrium.
In pre-prescription research, it is often necessary to determine the solubility of drugs in multiple solvents, such as water, 0.9% NaCl solution, dilute hydrochloric acid solution (0.1mol/L HCI), and dilute alkali solution (0.1mol/L NaOH) pH6. 8 Phosphate buffer and some specific solvents such as ethanol and methanol. The solubility measured by this method is also called equilibrium solubility (equilibrium solubility) or apparent solubility (apparent solubility).
For poorly soluble drugs and their oral dosage forms, such as tablets, capsules, suspensions, and suspensions for intramuscular injection, the dissolution of the drug in the body fluid of the absorption site is the rate-limiting step of drug absorption. When dissolution is a rate-limiting process, any factors that affect dissolution will also affect drug absorption. In actual work, the in vitro dissolution test method is usually used to determine the dissolution rate of the drug to predict the dissolution and release of the drug in the body.
At present, “United States Pharmacopoeia” (USP35) contains a variety of dissolution testing methods, including basket method, paddle method, reciprocating cylinder method, flow cell method, paddle disc method, rotating drum method, reciprocating bracket method and so on.
“Chinese Pharmacopoeia” 2010 edition two appendix stipulates 3 kinds of dissolution determination methods, including the first method (basket method), the second method (paddle method), and the third method (small cup method). Different methods and instruments can be selected according to different research and application purposes (refer to Appendix 1 of this book).
The application of dissolution testing is becoming more and more extensive, including prescription screening in the drug development stage, routine quality control of preparations, evaluation of the quality of drugs within the validity period, and prediction of the impact of drug release on drug effectiveness under different medication conditions (such as taking the medication before and after meals) , Evaluate the bioequivalence of the drug, evaluate the quality of the changed drug composition and production method after the market. In short, dissolution testing plays an important role in controlling the quality of medicines and predicting the effectiveness of medicines.
The partition coefficient (P) refers to the ratio of the concentration of the drug when it is dissolved in two immiscible solvents and reaches equilibrium. The oil/water partition coefficient (for example, n-octanol/water, chloroform/water) indicates the ratio of the drug in the oil phase and the water phase.
The dissolution, absorption, distribution and transportation of drugs in the body are related to the water solubility and fat solubility of the drug, that is, it is related to the drug oil/water partition coefficient. Generally speaking, drugs with a larger oil/water partition coefficient are easier to transport and absorb through cell membranes.
Since the solubility parameter of n-octanol is close to the solubility parameter of biofilm, it is one-half of 21.07 (J/cm³). Therefore, in order to more accurately predict the transportation of drugs in the body, n-octanol/water distribution is often used in the formulation design. Coefficient, and often measured by the shake flask method.
For example, after mixing water saturated with n-octanol and n-octanol saturated with water according to 1:1, add a standard amount of drug, shake it to equilibrium at a constant temperature, and determine the drug concentration in the two phases C oil and C water Calculate the ratio C oil/C water.
If the drug exists as a monomer in both phases, the partition coefficient is the ratio of the solubility of the drug in the two phases. The partition coefficient can be obtained by measuring the solubility of the drug in the two solvents.
The degree of drug dissociation has an important impact on the prescription of the drug and its kinetic parameters, and it is one of the physical and chemical properties worthy of attention. Under normal circumstances, the degree of dissociation of the drug greatly depends on the pH of the drug-containing medium. In the formulation and process research, the method of adjusting the pH of the medium is often used to make the drug ionize to a certain extent to meet the required drug solubility and formulation stability. Sex.
The degree of drug dissociation also has an important impact on the absorption, distribution, and elimination of drugs. Generally speaking, dissociated drugs are more difficult to be absorbed through biofilms, while non-dissociated drugs can often pass through lipid biofilms effectively. The relationship between the pH of the solution, the pK of the drug, and the dissociation state of the drug can be expressed by the Henderson-Hasselbalch equation.
The dissociation constant or pKa can usually be determined by potentiometric titration. According to the Henderson-Hasselbalch equation, if Ca and pKa are known, the solubility of the drug under any pH condition (the sum of the non-dissociation and dissociation solubility) can be predicted. Using the dissociation constant or pK., it is possible to predict whether the mixture will precipitate at a certain pH, and it also helps to select the appropriate salt of the drug.
Crystalline (crystalline forms, polymorphs) refers to the arrangement of molecules in the crystal lattice of a crystalline substance. Drugs often have more than one crystal form, called polymorphism, or polymorphism.
Many drugs have polymorphic forms. Due to the different crystal structure of the same drug, certain physical properties such as density, solubility, and dissolution rate are different, which may affect the dissolution and absorption of the drug in the body, which may affect the clinical of the drug to a certain extent. Efficacy and safety, especially the oral solid or semi-solid dosage form of some poorly soluble drugs, the crystal form has a greater impact. In addition to polymorphic forms, drug molecules may also exist in amorphous forms, which are always more soluble than the corresponding crystalline forms.
The evaluation of polymorphs of drugs is an important pre-prescription research content. If poorly soluble solid drugs need to be made into solid oral preparations, the crystal form of the raw material should be studied, because the preparation process may cause the transformation of the crystal form of the drug.
For a new compound, you should first study whether there are polymorphs, how many crystal forms, and whether there are amorphous forms, and study the differences in physical and chemical properties of different crystal forms (such as solubility, stability), etc., determine the target crystal form, and pass Pharmacology, toxicology and clinical trials to determine the pros and cons of the selected crystal form.
If the research on the polymorph of the drug is improper, it may cause a series of problems of the preparation variety, such as crystal precipitation, crystal form transformation, poor stability, and low bioavailability. Such as the cortisone acetate suspension for injection, if the wrong crystal form is used, agglomeration will occur after prolonged storage. For drugs with crystal forms, the crystal form inspection indicators should be set in the stability test to determine the appropriate storage conditions and ensure the stability of the crystal form.
When researching drug polymorphs, the commonly used methods include hot stage microscopy, thermal analysis, and infrared spectroscopy.
Go and X-ray etc.
Hygroscopicity refers to the phenomenon that a solid surface can absorb moisture from the surrounding air. Due to the large specific surface area of the drug, most of them have different degrees of hygroscopicity.In the humid air, it is easy to absorb some water from the process, resulting in wetting, decreased fluidity, agglomeration, liquefaction, etc., and even discoloration and decomposition. Decrease the rationale of the drug. The speed and extent of the absorption of water by the drug depends on the physical and chemical properties of the drug and the relative humidity (relathumidity, RH) of the environment.
Relevant
news
marketing@medicilon.com
